ArticleCureus2025
Intersection of Stargardt Dystrophy and AIDS: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The co-occurrence of Stargardt disease, hereditary macular dystrophy, and advanced AIDS is a very rare association. The intersection of these two conditions raises important clinical considerations, particularly in differentiating retinal changes induced by macular dystrophy from those associated with human immunodeficiency virus (HIV) infection or antiretroviral therapy (ART). In this case, a 54-year-old woman with a history of advanced HIV presented with severe visual impairment, with finger-counting acuity in both eyes. Ophthalmic examination revealed extensive bilateral retinal atrophy involving the posterior pole and mid-peripheral retina, along with macular pigmentary migration lesions. Imaging studies, including autofluorescence and fluorescein angiography, demonstrated a centrally hyperfluorescent area and a large hypofluorescent zone with surrounding hyperfluorescence. Optical coherence tomography (OCT) confirmed abnormal hyper-reflectivity in the outer retinal layers and an enlarged foveal depression. Genetic testing confirmed two biallelic pathogenic variants in the ABCA4 gene, validating the diagnosis of Stargardt disease. The patient was also tested for systemic infections, such as syphilis and toxoplasmosis, to rule out opportunistic ocular infections associated with HIV. Her management was tailored to address both her retinal dystrophy and her immunosuppressive state. This case underscores the need for regular ophthalmological monitoring in patients with hereditary retinal dystrophies and HIV, particularly those on ART. Further research is warranted to explore the impact of HIV and its treatments on the progression of macular dystrophies like Stargardt disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.